References

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

10.1161/cir.0000000000001309 · 2025 · External reference

P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs

10.1093/cvr/cvy201 · 2018 · External reference

HEALING-AMI Investigators. Effect of ticagrelor on left ventricular remodeling in patients with st-segment elevation myocardial infarction (HEALING-AMI)

10.1016/j.jcin.2020.08.007 · 2020 · External reference

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis

10.1016/j.jacc.2017.08.037 · 2017 · External reference

Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance

10.1016/j.jacc.2014.03.031 · 2014 · External reference

2020 AHA/ACC Key data elements and definitions for coronary revascularization: a report of the american college of cardiology/american heart association task force on clinical data standards (writing committee to develop clinical data standards for coronary revascularization)

10.1161/hcq.0000000000000059 · 2020 · External reference

EAU working group on male sexual and reproductive health. european association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction

10.1016/j.eururo.2021.06.007 · 2021 · External reference

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

10.1161/circulationaha.110.009449 · 2011 · External reference

Pharmacodynamic profile and prevalence of bleeding episode in east asian patients with acute coronary syndromes treated with prasugrel standard-dose versus de-escalation strategy: a randomized A-MATCH trial

10.1055/a-1346-3300 · 2021 · External reference

Evaluation of clinical methods for rating dyspnea

10.1378/chest.93.3.580 · 1988 · External reference

Effects of monotherapy with clopidogrel vs. aspirin on vascular function and hemostatic measurements in patients with coronary artery disease: the prospective, crossover I-LOVE-MONO

10.3390/jcm10122720 · 2021 · External reference

Efficacy of aspirin for vasculogenic erectile dysfunction in men: a meta-analysis of randomized control trials

10.1177/1557988320969082 · 2020 · External reference

Potential causal association between aspirin use and erectile dysfunction in European population: a Mendelian randomization study

10.3389/fendo.2023.1329847 · 2024 · External reference

Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status

10.1016/j.jacc.2013.02.044 · 2013 · External reference

Sexual function, anxiety, depression and coping after myocardial infarction: an exploratory study

10.1007/s11195-021-09715-x · 2022 · External reference

Enhanced electrical field stimulated nitrergic and purinergic vasoreactivity in distal vs proximal internal pudendal arteries

10.1016/j.jsxm.2017.09.013 · 2017 · External reference

Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil

10.1038/aja.2009.70 · 2010 · External reference

Lafuente-de-Carvalho JM, Correia-de-Sá P. Corpus cavernosum from men with vasculogenic impotence is partially resistant to adenosine relaxation due to endothelial A(2B) receptor dysfunction

10.1124/jpet.106.107821 · 2006 · External reference

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents

10.1016/j.ahj.2010.01.016 · 2010 · External reference

Influence of platelet reactivity on BARC classification in East Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study

10.1160/th15-05-0366 · 2016 · External reference

A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: a randomized controlled trial

10.1371/journal.pone.0182124 · 2017 · External reference

De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis

10.1038/s41569-023-00901-2 · 2023 · External reference

Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome

10.3389/fcvm.2022.1053867 · 2022 · External reference

Protocol update and issues in EASTYLE trial

10.54912/jci.2024.0004 · 2024 · External reference